UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 172

Sortiert nach

A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer

Annals of oncology, 2013-11, Vol.24 (11), p.2844-2849

2013

Volltextzugriff (PDF)

Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience

Bone marrow transplantation (Basingstoke), 2013-09, Vol.48 (9), p.1218-1223

2013

Volltextzugriff (PDF)

Phase I–II clinical trial design: a state-of-the-art paradigm for dose finding

Annals of oncology, 2018-03, Vol.29 (3), p.694-699

2018

Volltextzugriff (PDF)

Phase I II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome

Leukemia, 2008-02, Vol.22 (2), p.258-264

2008

Volltextzugriff (PDF)

PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies

Leukemia, 2017-03, Vol.31 (3), p.697-704

2017

Volltextzugriff (PDF)

Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALL

Bone marrow transplantation (Basingstoke), 2013-01, Vol.48 (1), p.26-31

2013

Volltextzugriff (PDF)

Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine

Journal of clinical oncology, 1997-02, Vol.15 (2), p.483-490

1997

Volltextzugriff (PDF)

Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients

Bone marrow transplantation (Basingstoke), 2017-04, Vol.52 (4), p.580-587

2017

Volltextzugriff (PDF)

Leukemia cell mobilization with G-CSF plus plerixafor during busulfan-fludarabine conditioning for allogeneic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2015-07, Vol.50 (7), p.939-946

2015

Volltextzugriff (PDF)

Bayesian sequential monitoring designs for single-arm clinical trials with multiple outcomes

Statistics in medicine, 1995-02, Vol.14 (4), p.357-379

1995

Volltextzugriff (PDF)

Comparison of 100-day mortality rates associated with i.v. busulfan and cyclophosphamide vs other preparative regimens in allogeneic bone marrow transplantation for chronic myelogenous leukemia: Bayesian sensitivity analyses of confounded treatment and center effects

Bone marrow transplantation (Basingstoke), 2004-06, Vol.33 (12), p.1191-1199

2004

Volltextzugriff (PDF)

A Strategy for Dose-Finding and Safety Monitoring Based on Efficacy and Adverse Outcomes in Phase I/II Clinical Trials

Biometrics, 1998-03, Vol.54 (1), p.251-264

1998

Volltextzugriff (PDF)

Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit

American journal of respiratory and critical care medicine, 1998-09, Vol.158 (3), p.876-884

1998

Volltextzugriff (PDF)

Dynamic change in phosphorylated platelet-derived growth factor receptor in peripheral blood leukocytes following docetaxel therapy predicts progression-free and overall survival in prostate cancer

British journal of cancer, 2008-11, Vol.99 (9), p.1426-1432

2008

Volltextzugriff (PDF)

Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma

Leukemia, 2015-09, Vol.29 (9), p.1945-1948

2015

Volltextzugriff (PDF)

New statistical strategy for monitoring safety and efficacy in single-arm clinical trials

Journal of clinical oncology, 1996-01, Vol.14 (1), p.296-303

1996

Volltextzugriff (PDF)

Evaluating multiple treatment courses in clinical trials

Statistics in medicine, 2000-04, Vol.19 (8), p.1011-1028

2000

Volltextzugriff (PDF)

Some extensions and applications of a Bayesian strategy for monitoring multiple outcomes in clinical trials

Statistics in medicine, 1998-07, Vol.17 (14), p.1563-1580

1998

Volltextzugriff (PDF)

Practical model‐based dose‐finding in phase I clinical trials: Methods based on toxicity

International journal of gynecological cancer, 2003-05, Vol.13 (3), p.251-261

2003

Volltextzugriff (PDF)

Some Covariance Models for Longitudinal Count Data with Overdispersion

Biometrics, 1990-09, Vol.46 (3), p.657-671

1990

Volltextzugriff (PDF)

Practical Bayesian Guidelines for Phase IIB Clinical Trials

Biometrics, 1994-06, Vol.50 (2), p.337-349

1994

Volltextzugriff (PDF)

Caspase 2 and Caspase 3 Protein Levels as Predictors of Survival in Acute Myelogenous Leukemia

Blood, 1998-11, Vol.92 (9), p.3090-3097

1998

Volltextzugriff (PDF)

Prognostic significance of preoperative MRI scans in glioblastoma multiforme

Journal of neuro-oncology, 1996, Vol.27 (1), p.65-73

1996

Volltextzugriff (PDF)

1 – 25 von 172

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(164)
Mit Volltextzugriff
(164)

Publikationsform

Artikel
(170)
Tagungsberichte
(2)

Sprache

Englisch
(172)
Japanisch
(22)

Erscheinungsjahr

n.n

Thema

Science & Technology
(110)
Humans
(105)
Life Sciences & Biomedicine
(97)
Medical Sciences
(59)
Biological And Medical Sciences
(58)
Oncology
(45)
Male
(43)
Mathematics
(43)
Middle Aged
(42)
Physical Sciences
(41)
Statistics & Probability
(41)
Female
(40)
Adult
(38)
Aged
(36)
Treatment Outcome
(32)
Bayes Theorem
(29)
Hematology
(29)
Mathematical & Computational Biology
(29)
Clinical Trials
(26)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(25)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer

Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience

Phase I–II clinical trial design: a state-of-the-art paradigm for dose finding

Phase I II study of gemtuzumab ozogamicin added to fludarabine, melphalan and allogeneic hematopoietic stem cell transplantation for high-risk CD33 positive myeloid leukemias and myelodysplastic syndrome

PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies

Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALL

Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia

Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine

Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients

Leukemia cell mobilization with G-CSF plus plerixafor during busulfan-fludarabine conditioning for allogeneic stem cell transplantation

Bayesian sequential monitoring designs for single-arm clinical trials with multiple outcomes

Comparison of 100-day mortality rates associated with i.v. busulfan and cyclophosphamide vs other preparative regimens in allogeneic bone marrow transplantation for chronic myelogenous leukemia: Bayesian sensitivity analyses of confounded treatment and center effects

A Strategy for Dose-Finding and Safety Monitoring Based on Efficacy and Adverse Outcomes in Phase I/II Clinical Trials

Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit

Dynamic change in phosphorylated platelet-derived growth factor receptor in peripheral blood leukocytes following docetaxel therapy predicts progression-free and overall survival in prostate cancer

Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma

New statistical strategy for monitoring safety and efficacy in single-arm clinical trials

Evaluating multiple treatment courses in clinical trials

Some extensions and applications of a Bayesian strategy for monitoring multiple outcomes in clinical trials

Practical model‐based dose‐finding in phase I clinical trials: Methods based on toxicity

Some Covariance Models for Longitudinal Count Data with Overdispersion

Practical Bayesian Guidelines for Phase IIB Clinical Trials

Caspase 2 and Caspase 3 Protein Levels as Predictors of Survival in Acute Myelogenous Leukemia

Prognostic significance of preoperative MRI scans in glioblastoma multiforme

Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

Suchergebnisse filtern